Related Experiment Videos
Prenatal testing for Duchenne and Becker muscular dystrophy.
1Paediatric Research Unit, United Medical School of Guy's Hospital, London.
Lancet (London, England)
|February 6, 1988
Summary
Genetic testing for Duchenne and Becker muscular dystrophy in pregnant women significantly reduced fetal risk assessment accuracy. Early carrier identification before pregnancy is crucial for informed reproductive decisions and resource allocation.
Area of Science:
- Medical Genetics
- Neuromuscular Disorders
Background:
- Duchenne and Becker muscular dystrophy are X-linked inherited disorders.
- Genetic counseling and testing are vital for at-risk families.
Purpose of the Study:
- To evaluate the utility of DNA restriction fragment length polymorphisms (RFLPs) for prenatal diagnosis.
- To assess the risk reduction for male fetuses in pregnancies at risk for these muscular dystrophies.
Main Methods:
- Analysis of DNA restriction fragment length polymorphisms (RFLPs).
- Testing was performed on 53 pregnant women with varying family histories of muscular dystrophy.
Main Results:
- RFLPs were informative in 51 out of 53 cases (96.2%).
- In 10 of 25 male fetuses tested, the risk was reduced to 5% or less.
- Sporadic cases accounted for 32 of the 53 requests.
Conclusions:
- Prenatal DNA testing is highly effective for Duchenne and Becker muscular dystrophy.
- Early referral of potential carriers before pregnancy improves outcomes.
- DNA banking for affected individuals facilitates future risk assessment for relatives.